drugset / Trial / NCT06361836
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will test the safety and effects of SBT777101 when given as a single dose to subjects with hidradenitis suppurativa. Increasing dose levels will be given after the safety at lower dose levels is shown.
Timeline
- Start
- 2024-10-09
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SBT777101 | Cell therapy | — | — |